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Abstract
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The influence of dynamics on solution state structure is a widely overlooked consideration in
chemistry. Variations in Gd3+ chelate hydration with changing coordination geometry and
dissociative water exchange kinetics substantially impact the effectiveness (or relaxivity) of monohydrated Gd3+ chelates as T1-shortening contrast agents for MRI. Theory shows that relaxivity is
highly dependent upon the Gd3+-water proton distance (rGdH) and yet this distance is almost never
considered as a variable in assessing the relaxivity of a Gd3+ chelate as a potential contrast agent.
The consequence of this omission can be seen when considering the relaxivity of isomeric Gd3+
chelates that exhibit different dissociative water exchange kinetics. The results described herein
show that the relaxivity of a chelate with ‘optimal’ dissociative water exchange kinetics is actually
lower than that of an isomeric chelate with ‘sub-optimal’ dissociative water exchange. When the
rate of molecular tumbling of these chelates is slowed, an approach that has long been understood
to increase relaxivity, the observed difference in relaxivity is increased with the more rapidly
exchanging (‘optimal’) chelate exhibiting lower relaxivity than the ‘sub-optimally’ exchanging
isomer. The difference between the chelates arises from a non-field dependent parameter: either
the hydration number (q) or rGdH. For solution state Gd3+ chelates, changes in the values of q and
rGdH are indistinguishable. These parametric expressions simply describe the hydration state of the
chelate – i.e. the number and position of closely associating water molecules. The hydration state
(q/rGdH6) of a chelate is intrinsically linked to its dissociative water exchange rate kex and the
interrelation of these parameters must be considered when examining the relaxivity of Gd3+
chelates. The data presented herein indicates that the changes in the hydration parameter (q/rGdH6)
associated with changing dissociative water exchange kinetics has a profound effect on relaxivity
and suggest that achieving the highest relaxivities in monohydrated Gd3+ chelates is more
complicated than simply “optimizing” dissociative water exchange kinetics.
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Chelates of Gd3+ are now routinely administered as contrast agents for MRI. After
intravenous injection these chelates extravasate through the pores at the endothelial
junctions of the vasculature into interstitial space. Time dependent modulation of the dipolar
interactions between the seven unpaired electrons of Gd3+ and proximate water protons
leads to a shortening of the water proton longitudinal relaxation time constant (T1). In T1weighted MR images this results in enhanced signal intensity in those regions to which the
agent is distributed. For agents that are currently in clinical use, distribution is a function of
a number of vasculature characteristics, such as blood flow and pore size; and the size of the
agent. The limited criteria by which these agents discriminate between tissue types limits the
diagnostic information that can be obtained by administering these contrast agents. These
limitations have provoked the idea of a new class of contrast agent: so-called “targeted
agents” would possess a structural component that is designed to bind to a biomarker
associated with a disease of interest.1 Binding of the agent will increase the localization of
the agent in regions where that biomarker is more abundant, thereby increasing MR signal
intensity of regions associated with the disease. Binding has one further effect: it will slow
the agent's rate of molecular tumbling, characterized by the correlation time τR.
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The theory of paramagnetic relaxation given by the Solomon-Bloembergen-Morgan (SBM)
equations (equations 1-3) describes the relaxation of water protons that occurs through
exchange of water molecules coordinated directly to the paramagnetic metal center.2-6 These
equations tell us that reducing the rate of molecular tumbling (making τR longer) will afford
a more effective contrast agent.7-9 This is critical because the Gd3+ chelates that are
currently used clinically have high detection limits; a typical dose (0.1 mmolkg−1) equates to
about 4.5 g of agent in a single bolus for a 70 kg human. Clearly, if biomarkers of disease,
which are present only in very low abundance, are to be detected by MRI then it is
absolutely critical that the detection limit of any “targeted agent” be much lower than those
of agents currently employed. To this end the SBM equations have been used to guide
research into improving the function of MRI contrast agents. These equations reveal several
parameters that may be manipulated by the chemist to control the effectiveness of an agent –
defined as the longitudinal relaxivity, r1. From the SBM equations τR is found to limit the
relaxivity of low molecular weight clinical agents. τR is readily made longer either by
increasing the size of the agent, or by coupling its molecular motion to that of a large (or
stationary) structure such as a protein or cell. However, it is commonly found that when τR
is made longer the relaxivity of a Gd3+ chelate is subsequently limited by the kinetics of
inner. sphere water exchange.10 If τM, the residence lifetime of a water molecule on Gd3+, is
too long then the coordination site on Gd3+is needlessly occupied by a ‘relaxed’ water
molecule preventing relaxation of other water molecules, slowing the catalysis of bulk
relaxation by the relaxation agent. This is the situation that prevails in all clinically approved
Gd3+ chelates; if the limiting effect of τR is lifted then slow water exchange kinetics become
limiting and the highest relaxivities are not realized.10 This realization has prompted
considerable research effort into the development of more rapidly exchanging Gd3+ chelates
that would, in principle, afford the highest relaxivities if the limiting effect of τR were lifted.
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Several other parameters expressed in the SBM equations are also potentially under the
control of the chemist. Relaxivity scales proportionally with the number of water molecules
coordinated directly to the Gd3+ ion, q, so increasing the number of water molecules directly
coordinated to Gd3+ will afford higher relaxivities. However, increasing the number of
vacant coordination sites on Gd3+ is also found to reduce the stability of the chelate.
Unchelated, the Gd3+ ion is quite toxic to mammals (LD50 ~ 0.35 mmolkg−1, i.v. in mice)11
and must therefore be administered in the form of a kinetically and thermodynamically
robust chelate.10,12 In all clinically approved agents the Gd3+ ion is chelated by an
octadentate polyaminocarboxylate ligand (DTPA or a derivative, or DOTA or a derivative)
and this leaves one coordination site available for occupation by water. Opening additional
coordination sites to water, and therefore decreasing the sites coordinated by the chelating
ligand, is generally found to cause the stability constant of a chelate to drop by as much as 3
orders of magnitude;13 suggesting that in practice, with perhaps a few exceptions,14-16 only
q = 1 chelates are suitable for in vivo use.
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The recent observation of nephrogenic systemic fibrosis (NSF) in some renally
compromised patients after administration of DPTA-based contrast agents further highlights
the importance of chelate stability as a consideration in contrast agent development.17,18
Even though Gd3+ chelates derived from DTPA are q = 1 chelates, it is now generally
accepted that they are not sufficiently robust to survive prolonged in vivo residence
completely intact and are only safe if the entire dose is excreted rapidly.12,19-21 Targeted
imaging applications also envisage prolonged in vivo residence lifetimes and as such Gd3+
chelates derived from DTPA should not be considered suited for the purpose. The Gd3+
chelates of DOTA and its derivatives are more thermodynamically stable and more
kinetically robust than their DTPA counterparts.22 They are more suitable for applications
that require prolonged in vivo lifetimes, and controversy surrounds the isolated cases in
which GdDOTA has been associated cases of NSF.23 In general, DOTA derivatives are
considered sufficiently stable for prolonged in vivo residence lifetimes, and therefore for
targeted applications. A further advantage of DOTA-derived chelates is the superior electron
spin relaxation characteristics (T1e and T2e) of these chelates. Electron spin relaxation is
sometimes cited as another modifiable parameter that regulates relaxivity. However, even
though considerable effort is being made to better understand this parameter,24-27 at present
its relationship with coordination chemistry is vague at best and at present the chemist is
really faced with accepting what a given chelate provides. However, in general DOTA
derivatives are on the whole found to exhibit somewhat more favorable electron spin
relaxation characteristics than their DTPA-based counterparts.28
Finally, one further parameter that also relates to hydration of the chelate can potentially
have a profound effect upon relaxivity. The distance from the metal to the inner sphere
water protons, rGdH, is most widely viewed as a fixed value. In spite of this, the value used
Inorg Chem. Author manuscript; available in PMC 2014 August 05.
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in the calculations and fitting of relaxation data of Gd3+ chelates varies quite a bit; with
values anywhere from 2.9 to 3.1 Å commonly used.29 Given that relaxivity scales to the
negative sixth power of rGdH, even small changes in this value would be expected to have
profound effects on relaxivity. Parker and co-workers have demonstrated that faster
dissociative water exchange kinetics are associated with weaker (i.e. longer) Gd3+-OH2
bonds.30,31 Our own results suggest that differences in rGdH associated with differing
dissociative water exchange rates may not be confined solely to consideration of “bond”
distances but that the differences in rGdH may be even greater in solution.32-34 These
differences in rGdH are comparatively small – certainly less than the range of values
commonly employed in the published data analyses. Such small variations in rGdH are very
difficult to quantify – they are less than the reported uncertainty in ENDOR measurements
for instance,35 and yet they could be large enough that they significantly impact relaxivity.
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Several research groups around the world, including ourselves, have developed q = 1 Gd3+
chelates that possess very fast dissociative water exchange kinetics.36-41 However, our
chosen approach is unique in that in addition to a chelate with very fast dissociative water
exchange kinetics the same methods can be applied to generate an isomeric chelate with
slower dissociative water exchange kinetics.34,42 This allows us, for the first time, to
compare the effects of accelerating inner-sphere dissociative water exchange on relaxivity.
To achieve this aim in slowly tumbling chelates, we have prepared prototypical targeted
contrast agents that employ a simple hydrophobic group that will cause the agent to bind to
various slowly tumbling systems, such as human serum albumin (HSA). The advantages of
this approach are that it is easy to achieve and binding to HSA is comparatively well
understood; furthermore it also allows our results to be compared to those obtained for
related systems that also bind HSA.

Results and Discussion
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Gd3+ chelates of DOTA-type ligands can exist in two coordination geometries: a square
antiprism (SAP) and a twisted square antiprism (TSAP). It has long been appreciated that
the water exchange kinetics of the TSAP isomer are considerably faster than those of the
SAP isomer.33,43 To attain the highest relaxivities a TSAP isomer should therefore be the
preferred coordination geometry. In solution these two coordination isomers can
interconvert and a mixture of both is usually observed – for GdDOTA itself the SAP isomer
is found to be the predominant structure (~85%).44 However, by appropriately substituting
the ligand framework the conformational changes by which the two isomers exchange can
be ‘frozen out’, producing a chelate that is ‘locked’ into a single coordination isomer.45,46
Careful consideration of the stereochemistry enables one coordination isomer to be selected
over the other.42 The two chelates S-RRR-Ln1 and S-SSS-Ln1 are locked into the SAP and
TSAP coordination geometries, respectively (Figure 1). Previous studies have demonstrated
that the water exchange kinetics of S-SSS-Gd1 (τM298 ≈ 6 ns) are more or less optimal for
attaining the highest relaxivities at current imaging fields (1.5 T).34 In contrast the water
exchange kinetics of S-RRR-Gd1 are considerably slower; τM298 ≈ 70 ns and yet close to
the optimal value (~ 20 – 40 ns) predicted for lower magnetic field strengths (0.5 T).34
Prototypical ‘targeted’ contrast agents derived from these conformationally rigid isomeric
chelates would allow the effect of varying dissociative water exchange kinetics to be probed
in the context of a targeted imaging approach. The two chelates were modified to
incorporate a hydrophobic biphenyl group (Gd4) that could then be used to slow the rate of
molecular tumbling of each chelate through a binding interaction with either poly-βcyclodextrin (poly-β-CD) or human serum albumin (HSA).
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The preparation of the isomeric chelates S-RRR-4 and S-SSS-4 is shown in Scheme 1. The
preparation of S-RRR-1 and S-SSS-1 has been reported previously34 and functionalization
of these ligands, by conversion to the corresponding isothiocyanate, is facile.48 Catalytic
hydrogenation using H2 over 10% palladium on carbon afforded the corresponding primary
amines, 2, in near quantitative conversions. The primary amines 2 were then converted into
the isothiocyanates 3 by reaction with thiophosgene. Biphasic reaction conditions were
employed with the thiophosgene dissolved in chloroform and the amine 2 dissolved in water
at pH 2. The pH of the reaction is crucial to its success since the stability of isothiocyanates
decreases as pH rises. Isothiocyanates react readily with primary amines under mildly basic
conditions. Accordingly, the isothiocyanates 4 were dissolved in water, the pH raised to 8
with sodium hydroxide and 4-phenylbenzylamine added with dioxane as a co-solvent to
facilitate dissolution. After stirring for 24 hours a solution of the appropriate lanthanide
chloride in water was added and the reaction stirred at room temperature for a further 48
hours. At periodic intervals the pH of the reaction was monitored and maintained above 6 by
addition of sodium hydroxide. The Ln3+ chelates of the two biphenyl conjugates S-RRR-4
and S-SSS-4 were isolated and purified by preparative HPLC. Each chelate was isolated as
the more favoured ‘corner’ isomer47,49 affording the structures shown in Figure 1. The
chelates obtained thusly are isolated as the conjugate acid and are poorly soluble in aqueous
solution; however, neutralization, by stoichiometric addition of NaOH, affords the chelates
as their sodium salts, in which form the chelates are freely soluble in water.
Relaxometric Studies of Biphenyl Conjugates in Solution
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The relaxivity of a discrete Gd3+ chelate in solution can be determined by measuring the
proton relaxation rate constant, R1 (= 1/T1) over a range of Gd3+ concentrations. Because R1
and [Gd3+] are linearly related in this case, regression analysis of these data affords the
relaxivity, r1, of the chelate from the slope of the line. This standard method of relaxivity
determination was applied to the chelates S-RRR-Gd4 and S-SSS-Gd4. Unexpectedly
however, neither chelate exhibited a linear dependence of R1 on [Gd3+] (Figure 2). In the
concentration range 5 to 1 mM linear relationships were observed affording unusually high
relaxivity values for each chelate (Table 1 and supplementary information). An abrupt
change in the slope of the line is then observed followed by a second linear region over the
concentration range 300 to 10 μM. In this region the slope of the line afforded relaxivity
values much closer to those normally expected for low molecular weight chelates at 20 MHz
and 25 °C (Table 1). This behaviour is very similar to that observed for other Gd3+ chelate
incorporating a long hydrocarbon groups, such as C17-AAZTA50 or a GdDOTAcalix[4]arene derivative.51 As in that case the change in relaxivity can be attributed to the
formation of micelles, in which the rotation of Gd3+ is slowed, at higher concentrations.
Gd3+ chelates with large aromatic substituents, such as calix[4]arenes, have previously been
shown to form micelles.51 The critical micelle concentrations (cmc) of the Gd4 chelates are
somewhat below 0.5 mM, in closer agreement with the value determined for C17-AAZTA
than calix[4]arene substituted DOTA derivatives (Table 1).50,51 The relaxivity values of
both isomers of Gd4, both above and below the cmc, are somewhat higher than found for
either the calix[4]arene49 derivatives or C17-AAZTA.50 In the former case this is most
likely a reflection of the slow exchange kinetics exhibited in this system.51 The latter case is
noteworthy because C17-AAZTA is a q = 2 chelate and would therefore be expected to have
a somewhat higher relaxivity than either Gd4 isomer: both q = 1 chelates. Given that the
water exchange kinetics of C17-AAZTA and S-RRR-Gd4 are comparable this suggests that
the primary difference between the chelates must arise from more effective slowing of
rotation with the biphenyl substituent relative to that afforded by the hydrocarbon chain,
perhaps through continued, weak intermolecular interactions. Strictly analogous behaviour
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has also been reported and discussed in the cases of functionalized Gd3+ DTPA,52 DOTA,53
and EGTA54 chelates.
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The formation of micelles can unambiguously be demonstrated by recording the nuclear
magnetic relaxation dispersion (NMRD) profiles of each chelate at concentrations above and
below the cmc. The NMRD profiles at low concentrations (0.2 mM) of S-RRR-Gd4 and SSSS-Gd4 are characteristic of small molecule Gd3+ chelates in which relaxivity is limited by
τR (Figure 3);10 the relaxivity is higher at very low fields, there is a dispersion around 1
MHz followed by a more gradual decrease in relaxivity at higher fields. However, the
profiles have two points of interest. Firstly, the relaxivity of the agents is quite high for
discrete chelates, and this can be attributed to either the increase in hydrodynamic volume
associated with the inclusion of a bulky biphenyl substituent in the structure, or weak
intermolecular associations – reducing the rate of molecular tumbling (longer τR). Secondly,
and perhaps more significantly, the two curves are almost identical across the entire
frequency range of the profile, but offset from one another by about 1.5 mM−1s−1. This same
observation can be made retrospectively for the previously reported NMRD profiles of SRRR-Gd1 and S-SSS-Gd1.34 The fact that these profiles are almost superimposable but
offset in this way, tells us that the primary difference between the two chelates cannot arise
from a parameter whose effect on relaxivity is modulated by changes in B0 such as τM, τR,
T1e or T2e. There is a very slight additional difference in the dispersions (0.5 to 5 MHz) of
the two profiles that suggests a small difference in one of these field-dependent parameters.
The primary difference between the two chelates must be a parameter with which relaxivity
scales directly: in other words either q or rGdH.

NIH-PA Author Manuscript

Hydration in Ln3+ chelates has been something a contentious matter for over a decade now.
The disagreements have largely arisen from differing opinions of how to describe
differences in hydration between chelates, the debate may appear largely one of semantics
but it arises because of the difficulty the scientist faces in describing hydration. Both q and
rGdH are parametric descriptors of hydration and the problem is how to define each for a
chelate in aqueous solution, and therefore in exchange. It has been possible to account for
some of the observed coordination chemistry of the later lanthanides (Ho3+ → Lu3+) by
invoking a TSAP coordination isomer that is entirely dehydrated (q = 0) in solution.44,55-57
However, there is no published evidence for the existence of a discrete, dehydrated TSAP
isomer of DOTA-type chelates of lanthanides from the middle of the series (Eu3+ and Gd3+).
In systems where changes in hydration leads to changes in the coordination geometry the
non-degenerate 5D0↔7F0 transition of the Eu3+ ion can be used probe hydration
equilibria.58 The Eu3+ coordination geometry in DOTA-type chelates changes only subtly
with changing hydration56 and the high resolution emission spectra (supplementary
information, S1) of both S-RRR-Eu4 and S-SSS-Eu4 each exhibit a single line for this
transition at about 578 nm. There are three possible explaations for this observation: each
chelate has a single hydration species (even though the S-SSS-Eu1 is q = 0.74 as determined
by Horrocks’ method);31 any change in hydration does not afford sufficient change in the
energy of this transition to resolve the different hydration species; or the spectrum affords a
time-average of all hydration species in solution.59 As discussed previously there exists no
good method for accurately determining rGdH in solution. Although Caravan and co-workers
have proposed ENDOR as a means of probing this parameter,35 it is important to note that
those experiments were performed at very low temperatures on static chelates in frozen
glasses, a condition that does not in any way resemble the situation of a chelate undergoing
exchange in solution. Herein lies the quandary; the hydration states of S-RRR-Eu1 and SSSS-Eu1 are very different when determined by Horrocks’ method – q = 0.97 and q = 0.74,
respectively – how should this difference be interpreted? Insight can be gained from two
very different pioneering studies. The work of Parker and co-workers31 has unambiguously
shown that Horrocks’ method does not provide simply the hydration number, in fact it
Inorg Chem. Author manuscript; available in PMC 2014 August 05.
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provides both the hydration number and the position of those water molecules in a single
parameter: i.e. Horrocks’ hydration state describes both q and rEuH in one parameter.
Significantly, the hydration state also accounts for molecules in the second coordination
sphere as well. In his pioneering relaxometric studies on paramagnetic metal ions Bertini,
encountered the same problem, and recognizing what Parker would later demonstrate, he
used a single parameter to describe the hydration state of the metal ion: q/rMH6.60,61 The
hydration states of the two Eu1 chelates determined by Horrocks’ method, unambiguously
demonstrate a difference in the hydration states of the two chelates.34 This difference can be
represented either as a difference in q, a difference in rGdH, or more properly as a difference
in q/r6. For the purposes of the data analyses performed herein we have employed values of
q/rGdH6 = 1372 nm−6 and 1127 nm−6 for S-RRR-Gd4 and S-SSS-Gd4, respectively. For
reasons of simplicity and familiarity these values can be considered to represent two q = 1
chelates in which rGdH increases by 0.1 Å or 3.3% (from 3.0 Å to 3.1 Å) on passing from SRRR-Gd4 to S-SSS-Gd4. Throughout this article we will employ this description of
hydration; however, the reader must recognize two important points: 1) although we will
describe q as fixed with only rGdH in variance, in truth either or both hydration parameters
may be different between the two chelates; 2) the values of q/rGdH6 for each chelate are not
known, the values, and the difference between them, that are employed herein are more
illustrative than precise representations of the hydration in these chelates. However, given
the previously noted differences of rLnH (2.8 % in the crystal, 4.5 % in solution)32-34
between SAP and TSAP isomers the difference seems reasonable and the values of rGdH lie
within the range of commonly used values for this type of analysis. Any errors in the values
employed will be reflected in deviations in the values of τR from the real values. Muller and
co-workers have shown that when fitting NMRD profiles variance in the value of rGdH,
usually fixed, causes a variance in the obtained value of τR.29 Thus, unless τR is
independently determined and fixed during fitting, there is some flexibility to the value of
rGdH employed provided that the effect on the value of τR is appreciated. This flexibility
may explain why it has not previously been found necessary to consider the effect of
variation in hydration (q/rGdH6) between chelates when undertaking these fittings.
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Taking this approach to hydration both NMRD profiles fit well to theory. In all NMRD
fittings herein the water exchange parameter τM has been taken from studies on the
corresponding isomer of Gd1, it is not possible to measure the water exchange kinetics of
Gd4 chelates directly by 17O NMR methods due to solubility constraints. The assumption
was made that the peripheral incorporation of a biphenyl group has no significant effect
upon the water exchange kinetics of the chelate. The τM value for S-RRR-Gd4 was fixed at
the value determined for the corresponding isomer of Gd1.34 A variation of this τM value by
± 30 ns resulted in a relaxivity change of less than 0.3 mM−1s−1 at all fields. In the case of
S-SSS-Gd4 fitting was found to be largely insensitive to small changes in τM over a range 5
– 10 ns and data were fitted using a τM value, 8 ns, that best fits the data. The values of τR
obtained from fitting the low concentration NMRD profiles of both chelates are somewhat
longer than expected for relatively small chelates (Table 2). This may reflect an
underestimation of rGdH on our part. Alternatively, these longer than expected values could
reflect an increased level of intermolecular π-π interaction (without forming micelles) that
will tend to slow rotation and increase relaxivity as discussed earlier. Effects of this type
have been observed by Merbach and Helm for other chelates including aromatic groups.62,63
The similarity in the values of τR is expected since the two chelates are isomeric. The
parameters Δ2 and τV are reflective of the zero-field splitting and its transient modulation,
respectively, which govern the electron spin relaxation time constants of the chelate. In both
isomers of Gd4 the value of τV is somewhat different (larger) than is usually obtained in this
type of exercise for these types of chelate. Crucially both isomers have very similar electron
spin relaxation characteristics, a feature that has been previously established through EPR
analysis of analogous chelates to the two isomers of the Gd1.26 Given that the relationship
Inorg Chem. Author manuscript; available in PMC 2014 August 05.
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between electron spin relaxation and coordination chemistry is poorly understood it is
difficult to point to a direct physical reason as to why τV is longer than might be expected.
However, it is worth noting that a marked lengthening of this parameter is very often
observed in macromolecular systems.10,64 That the difference between the two NMRD
profiles arises primarily from difference in hydration state between the two chelates is
shown by simulating an NMRD profile using the same parameters obtained from the fitting
of the profile of S-RRR-Gd4 but extending rGdH from 3.0 to 3.1 Å. This affords a curve that
almost exactly fits the experimental data obtained for S-SSS-Gd4 (supplementary
information Figure S2), indicating that almost the entire difference between the two profiles
is accounted for in the change in rGdH. Furthermore, constraining the hydration states of the
two chelates to the same value during fitting affords unrealistic values for other fitting
parameters (supplementary Figure S8 and Tables S1 and S2).

NIH-PA Author Manuscript
NIH-PA Author Manuscript

The NMRD profiles of the two isomers of Gd4 recorded at a 3.98 mM, above the cmc,
(Figure 4) are characteristic of more slowly tumbling chelates: a classical high field ‘hump’
is observed in each case indicating the formation of a slowly rotating species, micelles, at
higher concentrations. It should be noted that NMRD profiles for slowly rotating systems
are shown and fitted herein only in the high field region because of the known limitations of
SBM theory in the slowly rotating regime that render it unable to completely account for the
behaviour of more slowly rotating chelates at very low magnetic field strengths.65 These
profiles are notable because the high field relaxivity enhancement arising when molecular
tumbling is slow (longer τR) is greater for S-RRR-Gd4, the isomer (SAP) with the more
slowly exchanging water molecule. This is in direct contrast to the general expectation that
more rapid water exchange kinetics (up to an optimal value of about 6 ns at 1.5 T)7,34 will
afford higher relaxivities. Fitting these profiles to SBM theory, incorporating the LipariSzabo model,66,67 affords valuable information about the tumbling dynamics of each chelate
in the micelle. The advantage of the Lipari-Szabo model is that it separates the local and
global tumbling motions of the chelate, allowing the effect of local molecular motion on
relaxivity to be considered. Fitting was undertaken with the aforementioned difference of
0.1 Å in the values of rGdH used for the two isomeric chelates. The fits afforded comparable
values of τg and τl; the global and local molecular tumbling correlation times, respectively.
These results indicate that the micelles formed by each isomer of Gd4 are of comparable
size and that within each the Gd3+ chelate has broadly similar freedom of rotation. The
difference in relaxivity of the isomers of Gd4 in micelles can only partially be the result of
differences in molecular rotation between the two systems. The major difference between
the two profiles again stems from the longer rGdH value found for S-SSS-Gd4. This is
demonstrated by a simulated NMRD profile using the fitting parameters from the profile of
S-RRR-Gd4 but employing the hydration parameters from the SSSS-Gd4 profile – τM = 8 ns
and rGdH = 3.1 Å (dashed line, Figure 4). This simulation accounts for the majority of the
relaxivity enhancement observed for S-RRR-Gd4 and indicates that the primary limitation to
enhancing relaxivity at high fields for S-SSS-Gd4 is a combination of the longer rGdH value
observed for this chelate and a value of τM that is rather too short to optimize relaxivity at
20 MHz.
As previously noted the τM value of S-SSS-Gd4, at 8 ns, is somewhat shorter than optimal at
20 MHz, under the traditional SBM paradigm.10,34 This is reflected in a shift of the maxima
of the two relaxivity ‘humps’ in the NMRD profiles shown in Figure 4. The more rapidly
exchanging S-SSS-Gd4 exhibits a ‘hump’ maximum that is at 10 to 20 MHz higher field
than the more slowly exchanging S-RRR-Gd4, consistent with expectation based on the
different water exchange kinetics of the two isomers. However, it is important to note that
even at the higher fields where the exchange rate of S-SSS-Gd4 would be considered
optimal the relaxivity of SRRR-Gd4 remains higher and this must be a direct result of the
increase in rGdH.10,34
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Interactions of biphenyl conjugates with poly-β-cyclodextrin
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Hydrophobic groups such as the aromatic substituent of Gd4 are known to form inclusion
compounds with β-cyclodextrin (β-CD). Cyclodextrins themselves are not sufficiently large
to slow rotation to the extent that substantial gains in relaxivity can be realized, but
polymers of cyclodextrins are large enough and have previously been used to slow
molecular tumbling and increase relaxivity.68-70 Poly-β-cyclodextrin (poly-β-CD) contains
an average of 10 - 11 β-CD units, each of which can bind and slow the tumbling of Gd4. The
advantage of this approach is that, unlike the serum albumin binding described below, polyβ-CD affords only approximately equivalent binding sites and will slow the rotation of each
chelate it binds approximately equivalently. In consequence, the binding of Gd4 to poly-βCD conforms, to a first approximation, to a simple 1:1 binding model. Titrating a dilute
solution of Gd4 with poly-β-CD and measuring the change in water proton relaxation rate
affords typical binding curves for both isomers of Gd4 (Figure 5). The increase in water
proton relaxation rate as Gd4 is added to poly-β-CD is a clear indication of a reduction in the
rate of molecular tumbling of the Gd3+ chelates (longer τR) as the chelates bind to the
polymer. The data were fitted to a simple model that considers the presence of 11 equivalent
and independent binding sites, affording association constants and bound relaxivities
(r1bound) for the two isomeric chelates (Table 3).
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The association constants determined in this way (Table 3) are probably a good reflection of
the strength of the interaction between each isomer of Gd4 and a β-CD unit. Although these
values are an average over all β-CD of the polymer there is no reason to suppose that the
binding of one chelate by poly-β-CD will substantially change the binding of any of the
others and each binding site must be very similar, if subtly different. The binding of S-SSSGd4 to β-CD is somewhat stronger than that of S-RRR-Gd4 even though the same group is
responsible for binding in each case. Since these are interactions between chiral host and
chiral guest in each case, differences in the binding of the two isomers were expected. The
results of molecular modelling studies (below) further highlight how these differences in
interaction are likely to occur. Unlike Ka, the relaxivity of Gd4 bound to poly-β-CD is
expected to vary somewhat depending on the location of the β-CD unit in the polymer –
chelates bound closer to the middle of the molecular assembly could reasonably be assumed
to have less (or at least slower) motion of rotation than those closer to the ends. In this light
it is important to treat r1bound values as averaged values rather than absolute values for a
discrete chelate. Nonetheless, this exercise is highly instructive; the bound relaxivity (Table
3) of the more rapidly exchanging TSAP isomer again has lower value than the more slowly
exchanging SAP isomer when molecular tumbling is slowed.
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NMRD profiles of the two isomers of Gd4 were recorded under conditions that ensured > 96
% of the chelate was bound to poly-β-CD (Figure 6). Again only the high field region of the
profiles are shown and fitted. Notably the two profiles closely resemble those obtained for
the chelates in micelles. Fitting the profiles to SBM theory (including the Lipari-Szabo
model) affords similar rotational correlation times, τg and τl, for the two isomers of Gd4
bound to poly-β-CD (Table 4) indicating that differences in molecular tumbling between the
two isomers are not the primary cause of the difference in relaxivity. Yet again it is found
that the critical impact of the longer rGdH value of S-SSS-Gd4 is the primary cause of the
lower relaxivity observed for the more rapidly exchanging TSAP isomer. A profile
simulated with fitting parameters for SSSS-Gd4, but using the water exchange parameters
for S-RRR-Gd4, accounts for all of the difference between the profiles at the high and low
field regions of the relaxivity ‘hump’ and most (about 80%) of the ‘hump’ around 20 MHz
(dashed line, Figure 6). The remaining differences in relaxivity may be attributed to the
small differences that exist between the local rotations (τl) of the two chelates when bound
to poly-β-CD. The relaxivity maximum observed for each chelate exhibits the same field

Inorg Chem. Author manuscript; available in PMC 2014 August 05.

Avedano et al.

Page 10

dependence as observed in the micelle system – the more rapidly exchanging isomer
peaking at higher field – consistent with expectation.
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Interactions of biphenyl conjugates with Human Serum Albumin
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Titrating human serum albumin (HSA) into dilute solutions of Gd4 below the cmc clearly
demonstrates the relaxivity enhancement afforded by the interaction of the Gd3+ chelate
with the protein (Figure 7). As the amount of HSA present increases the relaxivity of each
chelate increases as the chelate binds to the protein and molecular tumbling is slowed.
However, unlike poly-β-CD with its approximately equivalent binding sites, HSA has
multiple, very different hydrophobic binding sites and is capable of binding a large number
of hydrophobic molecules simultaneously. Because chelate binding in proteins such as HSA
is allosteric, the binding of Gd4 at any given site alters the chelate-protein interaction at all
other binding sites. As a consequence, fitting this type of titration data does not provide
information with true physical meaning about the agent, its binding or relaxivity. A binding
model incorporating 3 equivalent binding sites on the protein describes the data for each
chelate quite well and allows a qualitative assessment of the titration data in Table 5. From
the inflection of the binding curve which occurs significantly before a 1:1 stoichiometry it is
clear that both chelates bind reasonably avidly to more than one site on the protein,
justifying the use a 3:1 binding model. The overall binding affinity of S-RRR-Gd4 appears
to be higher than that of S-SSS-Gd4. Furthermore, the effect of the longer rGdH value for SSSS-Gd4 is again evident as its relaxivity is evidently lower than that of S-RRR-Gd4.
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Relaxometric titrations cannot discriminate between chelates bound to different sites on the
protein and it is highly unlikely that either chelate is able to find three equivalent sites at
which to bind. To probe the binding interactions in more depth site specific binding assays
are required. The work of Sudlow and co-workers71,72 has provided a great deal of
information about the binding interactions of HSA as well as methods for probing these
interactions. Caravan and co-workers employed those methods to probe the interactions of
the clinical blood pool agent MS-325.73 Given the well-developed nature of this
experimental protocol identical techniques were used to probe the binding of each isomer of
Gd4 to HSA. A fluorescent probe specific for a particular biding site on HSA was added to a
solution of defatted HSA and its displacement by Gd4 followed by fluorescence. Warfarin is
a probe that is known to selectively bind in what Sudlow designated drug binding site I.71
When either isomer of Gd4 was titrated into the solution no displacement of warfarin from
HSA was observed (Supplementary Information, S4). This appears to indicate that there is
no binding of either isomer at this site; however, drug binding site I is a very large binding
domain and three distinct subdomains: a, b and c; have been noted within drug binding site
I.74 Warfarin binds in subdomain Ia which is the subdomain located closest to the mouth of
the binding pocket and between subdomains Ib and Ic. When bound, warfarin is known to
extend partially into both subdomains Ib and Ic, and therefore binding of Gd4 in either
subdomain Ib or Ic was expected to lead to at least partial displacement of warfarin from
drug binding site I. In light of the results from the relaxometric titrations the possibility that
drug binding site I is able to accommodate Gd4 and warfarin simultaneously, without
displacement of warfarin, cannot be excluded. Indeed the results of molecular modelling
studies (below) suggest that from an energetic perspective binding of the chelates in this site
remains a possibility. In contrast dansyl sarcosine binds selectively in what Sudlow
designated drug binding site II.71 Gd3+ chelates, including the clinical HSA binders MS.325
and GdBOPTA, are often found to bind in drug binding site II. Perhaps not unexpectedly
then addition of either isomer of Gd4 resulted in displacement of the dansyl sarcosine
causing a decrease in emission intensity (Supplementary Information, S4). Following the
methods of Caravan and co-workers, inhibition constants for the fluorescent probe at drug
binding site II can be determined for each isomer from which the strength of each
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association can be calculated (Table 6). The association constants determined in this way are
of a similar magnitude to that observed for MS-325. Notably the two isomers have quite
different association constants for binding at drug binding site II but these results are in
contradiction to those obtained from the relaxometric titration (Figure 7). The binding of SRRR-Gd4, globally stronger from the relaxometric titration, is the weaker of the two isomers
at drug binding site II. Two factors could contribute to this difference. Firstly, S-RRR-Gd4
could either be binding more strongly to other sites or binding to more sites on HSA – the
results of molecular modelling studies (below) suggest that even drug binding site I could be
occupied by this chelate. Secondly, the apparent r1bound value determined from the
relaxometric titration (Table 5), as noted previously, has no physical relation to the behavior
of any single chelate molecule. This value is a weighted average over chelate bound to all
sites, none of which are expected to have identical relaxivities, and the model allows for
only three bound chelates when in fact there could be many more. As a result, this parameter
may easily be an underestimate, and if this were indeed the case then the value of the
association constants determined from the fitting would tend to be overestimated.
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NMRD profiles were collected for both isomers under conditions designed to maximize the
amount of Gd4 bound to HSA (Figure 8). Conditions were chosen under which >99% of
each isomer of Gd4 is estimated to be globally bound to HSA, respectively (80 and 85 %
bound to site II, respectively, on the basis of the displacement experiments). Given the
distribution of environments in which Gd4 could be found in these systems any NMRD
fitting is without meaning and thus none was attempted. The same overall pattern is
observed as for the other slowly tumbling systems studied herein. High field relaxivity
‘humps’ are again observed for both chelates but the ‘hump’ maximum observed for SRRR-Gd4 is significantly higher than that of S-SSS-Gd4. This can again be attributed to the
difference metal-water distance, rGdH, between the two isomeric chelates. On the higher
field edge of the ‘hump’ the relaxivity of both agents falls off quickly, consistent with
theory. It is evident that the relaxivity of S-RRR-Gd4 falls off more quickly than that of SSSS-Gd4 until, at around 40 MHz, it falls below that of S-SSS-Gd4. This observation is
expected on the basis of the previously determined dissociative water exchange rates of each
chelate; that determined for S-SSS-Gd4 being more suitable for achieving higher relaxivities
at higher fields, according to the traditional SBM paradigm.10,34
Variable temperature relaxometry and molecular modelling studies
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One key assumption has been made in the analysis of all the relaxivity measurements herein:
the water exchange kinetics of both chelates remains virtually unaffected by the interactions
that slow the global rate of molecular tumbling. This is a point of particular relevance when
considering the agents bound to HSA as it has previously been reported that the interaction
of a chelate with the protein can affect its water exchange kinetics.73,75-77 The water
exchange kinetics of Gd3+ chelates are accurately determined by measuring the effect of
changing temperature on the 17O transverse relaxation rate of water in a solution of the
chelate.78,79 The water exchange kinetics of the two isomeric Gd1 chelates were determined
using this method.34 The limitation of this technique is that it requires relatively high
concentrations of Gd3+ (typically 10−2 M), much higher than the limits of solubility of HSA
or poly-β-CD. Samples cannot then be prepared in which sufficient chelate is present in
solution under conditions where the majority of the chelate is bound to the macromolecule.
The water exchange kinetics of the bound chelate cannot therefore be determined in this
manner. Caravan and co-workers proposed a method by which absolute quantification of
water exchange kinetics could be achieved from variable temperature 1H relaxation
measurements at much lower chelate concentrations using the corresponding Dy3+ chelate.75
It is generally considered that Ln3+ ions may be interchanged to afford differing types of
information that build up a picture of the overall coordination chemistry – as noted earlier
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where the Eu3+ chelate was studied to probe hydration equilibria. However, in our case there
are concerns that switching to a heavier Ln3+ ion (rather than the lighter Eu3+ ion) will bring
the TSAP isomer closer to a tipping point at which the hydration state of the chelates in the
TSAP coordination geometry are thought to abruptly begin to decrease. Dy3+ is adjacent to
Ho3+ in the lanthanide series and from recent crystallographic data on a TSAP Ho3+ chelate
it is evident that the hydration equilibrium of a TSAP Ho3+ chelate in solution is complex
indeed.80 The extent to which the hydration and exchange kinetics of a TSAP Dy3+ chelate
can be said to reflect those of a TSAP Gd3+, with its much simpler hydration behaviour, is
highly questionable. For this reason we took two different approaches to assess the
likelihood of changes in water exchange kinetics as the rate of molecular tumbling is
slowed.
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Firstly, molecular models were used to examine the orientation of the chelates when bound
to the macromolecules HSA and poly-β-CD. The results of modelling the interactions
between Gd4 and β-CD suggest very similar interactions for both isomeric chelates
(interaction energies of −24.4 ±1.4 kcal/mol and −25.7 ± 0.8 kcal/mol for the S-RRR-Gd4
and S-SSS-Gd4, respectively), consistent with the experimentally determined association
constants. The orientation of each isomeric chelate when bound to a β-CD unit (Figure 9)
may help explain the observed differences in the Ka for the two chelates. From the
molecular models it is clear that in each case the biphenyl group extends right through the
cyclodextrin binding pocket and it is the para- substituted phenyl and thiourea group that are
held in the binding cavity. Binding is thus the result of hydrophobic interactions between the
phenyl group and the inner surface of the cavity and hydrogen bonding interactions between
the thiourea group and the primary hydroxyl groups on the narrow rim. This binding mode
brings the chiral chelate in close proximity to the wider rim of the β-CD cavity. β-CD
interacts stereoselectively with chiral compounds81 and here the secondary hydroxyl groups
of the wider rim will interact differently with the chelates’ pendant arms depending upon
their orientation (either Λ or Δ). In each case the hydrophobic substituent is located on the
corner of the macrocycle (Figure 1) which orients the water coordination site such that it
will rotate pointing up and away from the β-CD unit, into the bulk water. It would be
expected that such an orientation would minimize interference in the water exchange
process of both isomers of Gd4 when bound to poly-β-CD. We may reasonably assume that
binding of Gd4 to β-CD does not significantly influence the rate of water exchange in either
chelate – any influence from this binding can reasonably be assumed to be very similar for
each isomeric chelate.
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Although experimentally no displacement of warfarin was observed, molecular modelling
studies suggest that both isomers of Gd4 are capable of binding in drug binding site I
(Figure 10). They would need to be capable of doing so without displacing warfarin and it is
possible to model the docking of both isomers Gd4 in such a way as to accommodate both
Gd4 and warfarin in the binding pocket. This is possibility arises only because the binding
pocket of drug binding site I is so large that accommodation of the Gd3+ chelate
simultaneously with the fluorescent probe is possible.54 Despite the size of this binding
pocket, docking calculations show the biphenyl groups held in the binding pocket with the
chelates held at some distance away from the mouth of the pocket by the para-phenyl linker.
This suggests a considerable degree of freedom of motion on the part of the chelate end of
the molecule. Although the calculated docking modes orient the water binding face of the
isomeric chelates in different directions relative to the protein surface, they are both pointing
essentially outward towards the bulk water. It is important to bear in mind that these are
single low energy minima of the chelate positions and are not a reflection of the timeaveraged orientation of the water binding face. Given the apparent freedom of motion of
each chelate when bound to HSA it seems unlikely that the exchangeable water molecule of
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either chelate is constrained to face towards the protein surface which could result in an
apparent deceleration of water exchange.
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Both isomers of Gd4 are experimentally found to bind to drug binding site II of HSA (Table
6). Docking calculations position S-SSS-Gd4 more deeply in the pocket than S-RRR-Gd4,
this permits the thiourea to engage the side chain of Ser489 in hydrogen bonding
interactions (Figure 10). Such a difference in binding mode may have a significant impact
on the freedom of local rotation of the two chelates. The chelate of S-SSS-Gd4 will be held
more closely to the surface of the protein which may reasonably be presumed to reduce local
rotation of the chelate. This would tend to increase relaxivity. However, the difference in
binding mode provides no reason to suppose that the water exchange rate of either chelate
would be affected by this binding. Both chelates will rotate locally around a point of
attachment (the corner of the macrocycle) which would seem to maintain the water
coordination site of each isomer pointing away from the protein surface and into the bulk.
These results may account for the stronger binding interactions observed for the S-SSS-Gd4.
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In a qualitative sense the accuracy of the binding predictions that come out of these
modelling exercises can be tested through variable temperature 1H relaxation measurements.
Since a number of parameters that are temperature dependent controls relaxivity, the
temperature profile of relaxivity can be very informative. This is of particular relevance here
since τM has a non-negligible effect upon the characteristic correlation time τC (equation 3)
when τR is long, i.e. in a slowly rotating system. Furthermore, τM is a primary determinant
of the effectiveness of the transfer of the paramagnetic effect to the bulk (equation 1).
From the Solomon-Bloembergen.Morgan equations (eqns 1-3) two limiting cases for innersphere relaxivity (r1is) may be defined:
The fast exchange regime, τM < T1M. For low molecular weight Gd3+ chelates this condition
typically occurs when τ 298M < 100 – 200 ns.
The slow/intermediate regime, τM ≥ T1M. In this regime the rate of water exchange is so
slow that the condition τM > T1M occurs over an extended temperatures range.
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In the fast exchange regime T1M is the primary determinant of inner-sphere relaxivity. At
low temperatures τR and T1,2e, and therefore τC, are long. The result is that T1M shortens
with decreasing temperature causing relaxivity to rise with decreasing temperature. In
slowly tumbling macromolecular systems the values of T1M are also shorter and the fast
exchange regime is not reached until τM298 < 30 ns. In the slow/intermediate exchange
regime inner-sphere relaxivity decreases with decreasing temperature and eventually tends
towards zero, following the increase of the water exchange lifetime.
The temperature relaxivity profiles of each isomer of Gd4 were recorded under three of the
molecular tumbling regimes described herein: as discrete chelates below the cmc; when
bound to poly-β-CD; and when bound to HSA (Figure 11). The temperature response of the
relaxivity of the discrete chelates (Figure 11a) reflects the known difference in water
exchange kinetics between the two isomeric chelates. At room temperature and above both
chelates are in fast-exchange regime and their relaxivity decreases exponentially with
temperature. As temperature dips below about 15 °C the behavior of the two chelates begins
to deviate: while S-SSS-Gd4 remains in the fast exchange regime, for S-RRR-Gd4 the value
of τM becomes so long as the temperature continues to drop that the chelate drops out of the
fast exchange regime and relaxivity begins to flatten out, eventually dropping below that of
S-SSS-Gd4. These temperature profiles can be fitted in terms of the parameters ΔHi# (i = M,
V, R, D) using the best-fit parameters from Table 2, and assuming an Eyring-type behaviour
for the parameters τR, τM, τV and D (the relative diffusion coefficient of solvent and Gd3+
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chelate). This procedure affords excellent fits that strongly support the previously
determined values of the τM values for the two Gd4 isomers.34
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In the two slowly tumbling systems (Figure 11b and c) the relaxivity of S-SSS-Gd4 exhibits
an increase in relaxivity with decreasing temperature similar to that observed for the discrete
chelates; indicating that the chelate remains in the fast exchange regime throughout. In
contrast, the relaxivity of S-RRR-Gd4 decreases with decreasing temperatures indicating
that the water exchange is slower. The decrease in T1M arising from slower molecular
tumbling drives the chelate into a slow/intermediate exchange regime. Notably, in each
profile there is a single temperature at which the relaxivity of the two isomers are equal and
this temperature increases as the system rotated more slowly, reflecting the effect of
decreasing T1M on S-RRR-Gd4 in the slow/intermediate exchange regime. What these data
show is that the relative rates of water exchange of the two isomers remain consistent across
the systems studied herein: S-RRR-Gd4 is a more slowly (but still rapidly) exchanging
chelate and S-SSS-Gd4 a more rapidly exchanging chelate in all these systems and binding
of these agents to either poly-β-CD and HSA does not affect this situation.

Conclusions
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Conventional wisdom in the field of contrast agent development has held that in order to
maximize relaxivity it is necessary to make two modifications to the low molecular weight
Gd3+ chelate currently employed in this role. First, the chelate must be prevented from
tumbling rapidly in solution, such that τR > 1 ns or so. Secondly, water exchange must be
accelerated to some optimal value, such that τM < 20 ns. While it is undeniably the case that
slow molecular tumbling and fast water exchange hold the key to the highest relaxivities, the
results presented herein show that conventional wisdom doesn't have it quite right. Preparing
two isomeric Gd3+ chelates with very similar electronic relaxation properties but very
different dissociative water exchange kinetics afforded the opportunity to undertake a direct
side-by side comparison of the effect of changing water exchange kinetics on relaxivity.
Theory indicates that one chelate should have had vastly superior relaxivity: that should
have been the one that exchanged water most rapidly (the TSAP isomer). Instead what we
observe is that the more slowly exchanging actually has substantially higher relaxivity.
Analysis of the relaxometric data reveals that the origin of this unique and unexpected result
lies in a difference in hydration state (q/rGdH6) between the two isomers. The lower
hydration state of the rapidly exchanging TSAP isomer and has a profoundly limiting effect
on relaxivity. These results demonstrate that far from being a matter of little importance, the
hydration state (number and position of water molecules in the inner coordination sphere)
can have a very profound effect on relaxivity. This demonstrates that, contrary to the
commonly performed superficial analyses of theory, simply ‘optimizing’ water exchange in
Gd3+ chelates is no guarantee that very high relaxivities will be attained.

Experimental
General Remarks
All solvents and reagents were purchased from commercial sources and used as received.
HPLC purifications were performed on a Waters δ-Prep 150 HPLC system using a
Phenomenex Luna C-18 reversed-phase (50 × 250 mm) column. In all cases absorbance was
monitored at 205 and 254 nm. The solvent system employed for the purification of chelates
eluted with water (0.037 % HCl) for 5 minutes and then with a linear gradient to 80 %
MeCN and 20 % water (0.037% HCl) after 40 minutes, at a flow rate of 50 mLmin−1. 1H
and 13C NMR spectra were recorded on a JEOL Eclipse 270 spectrometer at 270.17 MHz
and 67.93 MHz, respectively or on a Varian Mercury 300 spectrometer operating at 300.01
MHz and 75.47 MHz, respectively. The 1/T1 nuclear magnetic relaxation dispersion profiles
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of water protons were measured over a continuum of magnetic field strength from 0.00024
to 0.5 T (corresponding to 0.01 – 20 MHz proton Larmor frequency) on the fast fieldcycling Stelar Spinmaster FFC 2000 relaxometer equipped with a silver magnet. The
relaxometer operates under complete computer control with an absolute uncertainty in the 1/
T1 values of ± 1%. The typical field sequences used were the NP sequence between 40 and 8
MHz and PP sequence between 8 and 0.01MHz. The observation field was set at 13 MHz.
16 experiments of 2 scans were used for the T1 determination for each field. Additional data
at higher fields (30 - 70 MHz) were measured on a Stelar Spinmaster relaxometer equipped
with a Bruker electromagnet operating in the range 20 to 80 MHz. The synthesis of the
ligands S-SSS-2 and S-RRR-2 have been reported previously.34

(4S,7S,10S)–α,α’,α’’-Trimethyl-[(S)-2-(4-aminobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid (S-SSS-2)
The nitrobenzyl ligand S-SSS-1 (125 mg, 0.187 mmol) was dissolved in water (10 mL) and
10 % palladium on carbon (20 mg) was added. The reaction mixture was shaken on a Parr
Hydrogenator apparatus for 12 h under H2 (25 psi). The catalyst was removed by filtration
and the solvents lyophilized to afford the title compound as a colourless solid (111 mg, 94
%).
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1H

NMR (300 MHz, D2O pD 7), δ = 6.84 (2H, d, 3JH-H = 7 Hz, Ar), 6.62 (2H, d, 3JH-H = 7
Hz, Ar), 1.7-3.5 (22H, m br), 0.98 (9H, m, CH3); 13C NMR (75.5 MHz, D2O pD 7), δ = 7.3
(CH3), 7.5 (CH3), 7.7 (CH3), 43.3, 45.1, 45.2, 46.9, 47.2, 47.4, 54.8, 56.9, 57.9, 58.0, 58.2,
58.5, 59.8, 116.8 (Ar), 130.1 (Ar), 131.5 (Ar), 144.2 (Ar), 182.3 (CO2), 182.6 (CO2), 182.7
(CO2), 182.8 (CO2); m/z (ESMS ESI+): 590 (8 %, [H4L +K]+), 612 (55 %, [NaH3L +K]+),
634 (71 %, [Na2H2L +K]+), 656 (100 %, [Na3HL +K]+); νmax / cm−1 (ATR / pH 7): 3338
(NH), 2968, 2829, 1573 (CO2), 1462, 1408, 1258, 1227, 1166, 1126, 1032.
(4R,7R,10R)–α,α’,α’’-Trimethyl-[(S)-2-(4-aminobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid (S-RRR-2)
The title compound was prepared from S-RRR-1 according to the procedure employed for
S-SSS-2 and was isolated after removal of the solvents by lyopholization to afford a pale
yellow solid (156 mg, 92 %).
1H
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NMR (300 MHz, D2O pD 2), δ = 7.23 (4H, m, Ar), 2.6-4.1 (22 H, m br), 1.30 (9 H, m,
CH3); 13C NMR (75.5 MHz, D2O pD 2), δ = 13.6 (2 × CH3), 14.5 (CH3), 31.7, 32.4, 46.7
(br), 49.3 (br), 51.8, 53.4, 57.8, 58.7, 59.8, 61.6, 62.4 123.6 (Ar), 128.9 (Ar), 131.2 (Ar),
138.1 (Ar), 172.1 (2 × C=O), 175.1 (C=O), 176.0 (C=O); m/z (ESMS ESI+): 552 (83 %,
[H4L+H]+), 574 (45%, [H4L +Na]+) 590 (100 %, [H4L +K]+); νmax / cm−1 (ATR / pH 2):
3333 (NH), 2842, 2569, 1713 (CO2H), 1620, 15556, 1540, 1506, 1473, 1455, 1207, 1163,
1099.
(4S,7S,10S)–α,α’,α’’-Trimethyl-[(S)-2-(4-isothiocyanatobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid (S-SSS-3)
The amine S-SSS-2 (108 mg, 0.170 mmol) was dissolved in water (4 mL) and the pH of the
resulting solution adjusted to 2 by addition of a dilute HCl solution. Chloroform (6 mL) was
added to the reaction which was then stirred vigorously at room temperature. Thiophosgene
(68 mg, 0.59 mmol) was added to the reaction which was then stoppered and stirred
vigorously for 18 hours at room temperature. The reaction mixture was then transferred to a
separatory funnel and the chloroform layer was allowed to run off. The aqueous layer was
then washed with chloroform (2 × 15 mL). The aqueous layer was then collected and the
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solvents removed under reduced pressure to afford the title compound as a colourless solid
(111 mg, 95 %).

NIH-PA Author Manuscript

1H

NMR (300 MHz, D2O), δ = 7.35 (4H, m, Ar), 2.6 - 4.6 (22H, m br), 1.61 (3H, s br,
CHCH3), 1.50 (3H, s br, CHCH3), 1.33 (3H, s br, CHCH3); m/z (ESMS ESI+): 594 (39 %,
[M+H]+), 616 (100 %, [M+Na]+), 532 (10 %, [M+K]+); νmax / cm−1: 3345 (OH), 2986,
2102 (SCN), 1722 (C=O), 1516, 1455, 1394 1222, 1160, 1102, 1027; Anal. Found C = 44.8
%, H = 6.3 %, N = 9.7 %, C27H39N5O9S·3(H2O)·2(HCl) requires C = 45.0 % H = 6.6 % N =
9.7 %.
(4R,7R,10R)–α,α’,α’’-Trimethyl-[(S)-2-(4-isothiocyanatobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid (S-RRR-3)
The title compound was prepared from S-RRR-2 according to the procedure employed for
S-SSS-3 and was isolated after removal of the solvents removed under reduced pressure to
afford a colourless solid (127 mg, 93 %).
1H

NMR (300 MHz, D2O), δ = 7.15 (4H, m, Ar), 2.5-4.4 (22H, m br), 1.34 ( 9H, m, CH3);
m/z (ESMS ESI.): 592 (100 %, [M-H]−); νmax / cm−1: 2924, 2098 (SCN), 1716 (C=O),
1558, 1520, 1506, 1456, 1394, 1204, 1097.
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(4S,7S,10S)–α,α’,α’’-Trimethyl-[(S)-2-(4-[3-(biphenyl-4-ylmethyl)thioureido]phenyl
methyl)]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate gadolinium(III) chelate
(H[Gd(S-SSS-4)])
The isothiocyanate S-SSS-3 (102 mg, 0.150 mmol) was dissolved in water (5 mL) and the
pH of the solution adjusted to 8 (1M NaOH solution). The solution was stirred at room
temperature and a solution of 4-phenylbenzylamine (38 mg, 0.21 mmol) in dioxane (5 mL)
was added. The reaction mixture was stirred at room temperature for 18 hours. A solution of
gadolinium chloride hexahydrate (64 mg, 0.17 mmol) in water (2 mL) was then added to the
reaction, the pH being maintained at 6 by periodic addition of a 1 M solution of NaOH. The
reaction was stirred at room temperature for 48 hours. The solvents were removed in vacuo
and the residue dissolved in a mixture of water and THF prior to HPLC purification. After
removal of the HPLC eluent by lyophilisation the title compound was obtained as a
colourless solid (58 mg, 43%).
HPLC RT = 32.77 min; m/z (ESMS ESI−): 930 (100 %, [GdL]−), the appropriate isotope
pattern was observed; Anal. Found C = 46.9 %, H = 6.0 %, N = 8.0 %,
C40H49N6O8SGd·5(H2O) requires C = 47.0 % H = 5.8 % N = 8.2 %.
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(4R,7R,10R)–α,α’,α’’-Trimethyl-[(S)-2-(4-[3-(biphenyl-4-ylmethyl)thioureido]phenyl
methyl)]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate gadolinium(III) chelate
(H[Gd(S-RRR-4)])
The title compound was prepared from S-RRR-3 according to the procedure employed for
GdS-SSS-4 and was isolated after removal of the solvents by lyophilisation to afford a
colourless solid (49 mg, 39%).
HPLC RT = 31.55 min; m/z (ESMS ESI−): 930 (100 %, [GdL]−), the appropriate isotope
pattern was observed
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(4S,7S,10S)–α,α’,α’’-Trimethyl-[(S)-2-(4-[3-(biphenyl-4-ylmethyl)thioureido]phenyl
methyl)]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate europium(III) chelate
(H[Eu(S-SSS-4)])
The title compound was prepared from S-SSS-3 and europium chloride hexahydrate
according to the procedure employed for GdS-SSS-4 and was isolated after removal of the
solvents by lyophilisation to afford a colourless solid (52 mg, 40%).
HPLC RT = 33.73 min; 1H NMR (300 MHz, D2O), δ = 18.97 (NCH2-Hax), 17.93 (2H,
NCH2-Hax), 17.20 (NCH2-Hax), 8.35 – 6.0 (17H, m br, Ar and CH2Ar), 0.77 (NCH2-Heq),
0.84 (2H, NCH2-Heq), −0.56 (CH3), −1.11 (NCH2-Heq), −2.06 (CH3), −2.36 (NCH2-Hax),
−2.74 (NCH2-Hax), −3.04 (CH3), −3.99 (NCH2-Hax), −4.76 (NCH2-Hax), −5.18 (2H, NCH2Heq) –5.48 (NCH2-Heq), −6.69 (Hac), −7.14 (Hac), −7.84 (Hac), −9.73 (Hac), −11.57 (Hac);
m/z (ESMS ESI−): 925 (100 %, [EuL]−), the appropriate isotope pattern was observed;
Anal. Found C = 41.5 %, H = 5.5 %, N = 7.1 %, C40H48N6O8SEuNa·11(H2O) requires C =
41.9 % H = 6.1 % N = 7.3 %.
(4R,7R,10R)–α,α’,α’’-Trimethyl-[(S)-2-(4-[3-(biphenyl-4-ylmethyl)thioureido]phenyl
methyl)]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate europium(III) chelate
(H[Eu(S-RRR-4)])
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The title compound was prepared from S-RRR-3 and europium chloride hexahydrate
according to the procedure employed for GdS-SSS-4 and was isolated after removal of the
solvents by lyophilisation to afford a colourless solid (44 mg, 37%).
HPLC RT = 32.23 min; 1H NMR (300 MHz, D2O), δ = 37.99 (NCH2-Hax), 36.20 (NCH2Hax), 35.55 (NCH2-Hax), 35.34 (NCH2-Hax), 11.59 (1H, d, 2JH-H 7 Hz, NCHCH2Ar), 9.74
(1H, d, 2JH-H 7 Hz, NCHCH2Ar), 8.45 (2H, aa′, 2JH-H 13 Hz, NHCH2Ar), 7.80 (3H, m, Ar),
7.76 (2H, d, 3JH-H 8 Hz, para-substituted Ar), 7.67 (2H, t, 3JH-H 7 Hz, Ar), 7.44 (2H,
d, 3JH-H 8 Hz, para-substituted Ar), 7.24 (2H, d, 3JH-H 8 Hz, para-substituted Ar), 7.03 (2H,
d, 3JH-H 8 Hz, para-substituted Ar), 1.51 (NCH2-Heq), 0.78 (NCH2-Heq), 0.27 (NCH2-Heq),
−1.02 (NCH2-Heq), −2.92 (CH3), −3.73 (CH3), −4.05 (CH3), −5.80 (NCH2-Hax), −6.06
(NCH2-Hax), −6.97 (NCH2-Hax), −7.66 (2H, NCH2−Hax and NCH2-Heq), −9.90 (NCH2Heq), −11.37 (NCH2-Heq), −12.70 (Hac), −14.64 (Hac), −19.50 (Hac), −20.17 (Hac), −20.31
(Hac); m/z (ESMS ESI−): 925 (100 %, [EuL]−), the appropriate isotope pattern was
observed.
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Molecular Modelling—All modelling and docking procedures were carried out using the
MOE molecular modelling package (MOE Version 2004.03 Chemical Computing Group
Inc. Montreal, Canada). The structures of the chelates of Gd4 were built from the crystal
structure of the DOTA-type chelates obtained from the Cambridge Structural Database
(entry code JOPJIH; www.ccdc.cam.ac.uk/) and modelled using the Moe-Builder module
keeping the Gd3+ coordination cage fixed. Conformational analysis of the isomeric Gd4
chelates was performed by a simulated annealing molecular dynamics (SAMD) method.
High-temperature MD calculations were carried out at 1000 K with the starting velocities
calculated from the Boltzmann distribution. Each simulation ran for 2000 ps in steps of 0.1
fs with coordinates saved every 2 ps resulting in 1000 conformations. Each conformation
was subject to an energy-minimization step until 0.01 convergence and then to a second
molecular dynamic at 300 K for 20 interations, followed by conjugate gradient energy
minimization until a convergence of 0.001. Clustering of conformations was performed by
considering two identical conformers when their difference in energy was below 1 kcal
mol−1 and their RMSD less than 3.0 Å. The structure of β-CD was taken from the CSD
(entry code BCDEXD10). The high-resolution three-dimensional coordinates of human
serum albumin (HSA) was obtained from the Protein Data Bank (PDB code 1E7H). Prior to
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docking calculations the structures of HSA and β-CD were prepared by adding hydrogen
atoms and completing missing atoms. The starting positions for the docking procedure were
obtained by modifying the ligand positions and orientations to optimize binding geometry
while filling the available space in the HSA drug sites I and II and in the β-CD cavity.
Minimization was achieved by a multistep procedure, until convergence was less than 0.01
kcal mol−1 Å−1. For all calculations a modification of the Amber99 force field82 was used
with in-house parameterization to treat Gd3+ chelates within the framework of the ionic
method.50 The docking procedure was performed using the Moe-Dock module with Tabu
Search with 10 runs, 1000 steps per run. The ligand binding moiety was kept flexible during
the docking calculations. For the β-CD docking the solvent was modelled by using a
dielectric constant equal to 20, whereas for the HSA docking an implicit solvation
contribution (continuum model) was included to model solvent effects83 in the docking
calculations. The results of the docking calculations were sorted by utilizing a force-fieldbased scoring function and for each isomer the five best poses were chosen comparing the
interaction energies.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ABBREVIATIONS
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SYNOPSIS: A divergence of expectation and reality
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Theory often leads to an expectation that very fast water exchange is required to afford
the highest relaxivity Gd3+ chelate. In practice, of two isomeric Gd3+ chelates, the one
with the slowest water exchange affords the highest relaxivity.
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Chart 1.

The structures of conformationally rigid Ln3+ chelates.
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Figure 1.
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The lowest energy conformations of S-RRR-Gd4 (left, orange) and S-SSS-Gd4 (right,
green) obtained by Simulated Annealing Molecular Dynamics conformational analysis.
These structures highlight the different coordination geometries of the two chelates
characterized by different torsion angles (φ) and the position of the hydrophobic substituent
– in each case located on the corner of the macrocyclic ring in an approximately similar
position to that suggested by 2D NMR experiments.47 Hydrogen atoms have been omitted
for clarity.
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Scheme 1.
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The synthesis of the lanthanide chelates of S-SSS-4, the chelates of S-RRR-4 were
synthesized according to the same synthetic scheme. Reagents and conditions: i. H2 and
10% Pd on C; ii. SCCl2 / CHCl3 / H2O pH 2; iii. 4-phenylbenzylamine / dioxane / H2O pH
8; iv. LnCl3.6H2O, pH 6.
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Figure 2.

Plots of the paramagnetic 1H relaxation rate (R1p) versus Gd3+ chelate concentration for SRRR-Gd4 (top) and S-SSS-Gd4 (bottom) at 20 MHz and 25 °C, highlighting the change in
relaxivity with changing chelate concentration.
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Figure 3.
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The 1H 1/T1 NMRD profiles of S-RRR-Gd4 (SAP, open diamonds) and S-SSS-Gd4 (TSAP,
closed circles) recorded at 0.2 mM and 25 °C. Dashed lines represent the calculated outersphere contribution to relaxivities.
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Figure 4.
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The high field region of the 1H 1/T1 NMRD profiles of S-RRR-Gd4 (SAP, open diamonds)
and S-SSS-Gd4 (TSAP, closed circles) recorded at 3.98 mM and 25 °C. Solid lines represent
fits to the data, the dashed line is a simulated profile taking the fitting parameters from the
profile of S-RRR-Gd4 but applying the water exchange parameters τM and rGdH from the SSSS-Gd4 profile. Profiles including the low field region are provided in the supplementary
information (S3, S5 & S7).
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Figure 5.

The effect of poly-β-CD on the longitudinal relaxation rate (20 MHz, 25 °C) of dilute
solutions (0.17 mM) of S-RRR-Gd4 (SAP, open diamonds) and S-SSS-Gd4 (TSAP, closed
circles).
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Figure 6.

The 1H 1/T1 NMRD profiles of S-RRR-Gd4 (red diamonds) and S-SSS-Gd4 (blue circles)
recorded at [Gd3+] = 0.17 mM in the presence of 6 mM poly-β-CD at 25 °C.
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Figure 7.
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Relaxometric titrations HSA of into 100 μM solutions of S-RRR-Gd4 (SAP, open
diamonds) and S-SSS-Gd4 (TSAP, closed circles) at 20 MHz and 25 °C. A qualitative data
fit is provided (Table 5) using a binding model with 3 equivalent binding sites.
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Figure 8.
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The 1H 1/T1 NMRD profiles of solutions of the two isomers of Gd4 (0.15 mM) and HSA
(1.8 mM): S-RRR-Gd4 (open symbols); and S-SSS-Gd4 (closed symbols) recorded at 25 °C.
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Figure 9.

Results of the calculated docking procedure applied to β-CD and S-RRR-Gd4 (orange); and
β-CD and S-SSS-Gd4 (green). The β-CD surface is depicted with a red semi-transparent
Gauss-Connolly surface. Both isomers place the para-phenyl group inside the hydrophobic
cavity, with the thiourea moiety forming hydrogen bonding interactions with the primary
hydroxyl groups of the narrow rim.
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Figure 10.

Calculated docking of S-RRR-Gd4 (orange); and β-CD and S-SSS-Gd4 (green) to HSA: a)
to drug binding site I; b) to drug binding site II. The hydrogen bonding interaction between
S-SSS-Gd4 with Ser489 (drug binding site II) is highlighted in purple. Hydrogen atoms have
been omitted for clarity.
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Figure 11.

Variation in the paramagnetic 1H relaxivity of S-RRR-Gd4 (open symbols) and SSSS-Gd4
(closed circles) at 20 MHz: a) as discrete chelates in solution below the cmc; b) bound to
poly β-CD; and c) bound to HSA at the same concentrations as in Figure 8. Solid lines are a)
fits to the data and b) and c) a guide to the eyes only.
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Physicochemical properties of S-RRR-Gd4 and S-SSS-Gd4 obtained from the 1/T1 versus concentration plots
in Figure 2.
a
cmc / mM

r1 / mM−1s−1 below cmc

above cmc

S-RRR-Gd4

0.42 ± 0.02

10.7

40.8

S-SSS-Gd4

0.29 ± 0.02

9.0

28.2

Chelate

a

cmc = critical micelle concentration
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Table 2
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Best-fit parameters

a,b

of the NMRD profiles of S-RRR-Gd4 and S-SSS-Gd4 in Figures 3 and 4.

[Gd3+] = 0.20 mM

[Gd3+] = 3.98 mM

S-RRR-Gd4

S-SSS-Gd4

S-RRR-Gd4

S-SSS-Gd4

3.0

3.1

3.0

3.1

b
τM / ns

70

8

70

8

Δ2 / 1019 s−1

0.62

0.61

2.4

2.6

τV / ps

42

45

29

20

τR / ps

229

220

-

-

τg / ns

-

-

3.84

3.38

τ1 / ns

-

-

0.45

0.43

-

-

0.34

0.33

b

rGd-H / Å

S

2

a

Fitting used a = 3.8 Å, 298D = 2.24×10−5 cm2 s−1 and q = 1.
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b

parameter fixed during fitting.
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Table 3

Fitting parameters for the binding of the two isomers of Gd4 to poly-β-CD
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Ka / M−1

S-RRR-Gd4
S-SSS-Gd4

a

r1bound / mM−1s−1

0.51 ± 0.05 × 103

46 ± 0.7

103

30 ± 0.5

0.87 ± 0.07 ×

a

Measured at 20 MHz and 25 °C.
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Table 4

Best-fit parameters of the NMRD profiles (25 °C) of the inclusion complexes of the two isomers of Gd4 with
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poly-β-CD.

a

S-RRR-Gd4

S-SSS-Gd4

3.0

3.1

τM / ns

70

8

Δ2 / 1018 s−1

2.8

3.7

τV / ps

18

12

τg / ns

4.2

3.6

τ1 / ns

0.40

0.45

S2

0.45

0.42

b
rGd-H / Å
b

a

Fitting used a = 3.8 Å, 298D = 2.2×10−5 cm2 s−1 and q= 1.

b

parameter fixed during fitting.
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Table 5
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Binding parameters obtained from the qualitative fit of the relaxometric titration of HSA with S-RRRGd4 and S-SSS-Gd4 using a 3:1 binding model with equivalent binding sites.
a

a

KHSA-Gd4 (× 103 M−1)

r1bound (mM−1s−1)

S-RRR-Gd4

71.3 ± 12.4

46.8 ± 0.9

S-SSS-Gd4

49.7 ± 7.9

37.6 ± 0.6

a

apparent values (see text)
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Table 6
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The association constants of the two isomeric biphenyl conjugates Gd4 in the two drug binding sites of HSA
determined at 25 °C.
Fluorescent probe

Binding Site

KHSA-Gd4 / M−1 S-RRR-Gd4

S-SSS-Gd4

Warfarin

I

n.d.

n.d.

Dansyl sarcosine

II

9.2 ± 0.5×

10−3

22.1 ± 1.9 ×

a

MS-325
n.d.
10−3

11.8 × 10−3

a

taken from reference 73 and determined at 37 °C; n.d. indicates that no displacement of the fluorescent probe was detected.
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